share_log

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 22, 2022 16:47
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more